Adherium Limited (ADR.AX)
Adherium Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Melbourne, VIC, AU. The stock last traded at $0.11, up 0.00% on the session, giving a market capitalisation of $2.1M. Its beta of 1.04 implies it has historically moved more than the broad market.
Adherium Limited specializes in developing, manufacturing, and providing advanced digital health solutions. The company's core mission is to enhance medication adherence for individuals managing chronic conditions in key international markets, spanning New Zealand, Australia, Europe, North America, and Asia. A central offering is Hailie, a comprehensive system engineered to optimize medication use for patients suffering from chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD). This innovative solution integrates Bluetooth-enabled Hailie sensors, which discreetly attach to patients' inhalers to deliver immediate feedback. The Hailie ecosystem is further supported by an intuitive mobile application and a dedicated online portal. Established in 2001, Adherium Limited is headquartered in Auckland, New Zealand.
Adherium Limited is most often compared with the following Healthcare names: